“Current Trends and Controversies in the Diagnosis and Treatment of Hypertension” was presented at during the Canadian Society of Hospital Pharmacy Professional Practice Conference the morning of Wednesday February 4th. The program has been accredited by the Canadian Council on Continuing Education in Pharmacy (CCCEP File 853-0109L1FT).
- The first presentation by Dr. Phil McFarlane "Did oNTARGET Kill All Use of ACEi and ARB Combination Therapy may be downlaoded by using the following link: ACEi and ARB in combination - Dr. Phil Mcfarlane
- The second presentation given by Tom Smiley BSc Phm, PharmD, on the care gap in the current treatment of hypertension, the pathophysisiology of Renin Angiotensin Aldosterone System and mechanisms of RAAS Inhibition (ACE, ARB and DRI’s), CHEP guidelines, and the importance of Home Blood Pressure Monitoring is available for you to download.
To download the powerpoint version of this presentation, select the 'Paperclip' icon on the left side of the slide player. The file link is available there.